Bmc Medical Genetics

BackgroundThe beta-2-Adrenergic receptor (ADRB2) gene on chromosome 5q33.1 is an important immunoregulatory factor. We and others have previously implicated chromosomal region 5q31-33 for contribution to the genetic susceptibility to Graves disease (GD) in East-Asian populations. Two recent studies showed associations between the single nucleotide polymorphism (SNP) rs1042714 in the ADRB2 gene and GD. In this study, we aimed to fully investigate whether the ADRB2 gene conferred susceptibility to GD in Chinese population, and to perform a meta-analysis of association between ADRB2 and GD.MethodsApproximately 1 kb upstream the transcription start site and the entire coding regions of the ADRB2 gene were resequenced in 48 Han Chinese individuals to determine the linkage disequilibrium (LD) patterns. Tag SNPs were selected and genotyped in a case-control collection of 1,118 South Han Chinese subjects, which included 428 GD patients and 690 control subjects. A meta-analysis was performed with the data obtained in the present samples and those available from prior studies.ResultsFifteen SNPs in the ADRB2 gene were identified by resequencing and one SNP was novel. Ten tag SNPs were investigated further to assess association of ADRB2 in the case-control collection. Neither individual tag SNP nor haplotypes showed association with GD in Han Chinese population (P > 0.05). Our meta-analysis of the ADRB2 SNP rs1042714 measured heterogeneity between the ethnic groups (I2 = 53.1%) and no association to GD was observed in the overall three studies with a random effects model (OR = 1.13, 95% CI, 0.95 to 1.36; P = 0.18). However, significant association was found from the combined data of Caucasian population with a fixed effects model (OR = 1.18, 95% CI, 1.06 to 1.32; P = 0.002; I2 = 5.9%).ConclusionOur study indicated that the ADRB2 gene did not exert a substantial influence on GD susceptibility in Han Chinese population, but contributed to a detectable GD risk in Caucasian population. This inconsistency resulted largely from between-ethnicity heterogeneity.

[1]  Li Jin,et al.  Genome-wide scan of Graves' disease: evidence for linkage on chromosome 5q31 in Chinese Han pedigrees. , 2003, The Journal of clinical endocrinology and metabolism.

[2]  T. Ogihara,et al.  Genetic heterogeneity in association of the SUMO4 M55V variant with susceptibility to type 1 diabetes. , 2005, Diabetes.

[3]  Yusuke Nakamura,et al.  An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis , 2003, Nature Genetics.

[4]  K. Migita,et al.  Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population. , 2006, The Journal of clinical endocrinology and metabolism.

[5]  Judy H. Cho,et al.  Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease , 2007, European Journal of Human Genetics.

[6]  M. Vanderpump,et al.  The Epidemiology of Autoimmune Thyroid Disease , 1999 .

[7]  K. Jażdżewski,et al.  beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease. , 2007, International journal of molecular medicine.

[8]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[9]  P. Ghahramani,et al.  Influence of genetic polymorphisms in the β2-adrenoceptor on desensitization in human lung mast cells , 2000 .

[10]  M. Munakata,et al.  Molecular-Based Haplotype Analysis of the β 2-Adrenergic Receptor Gene (ADRB2) in Japanese Asthmatic and Non-Asthmatic Subjects. , 2006, Allergology international : official journal of the Japanese Society of Allergology.

[11]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[12]  S. Liggett,et al.  Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression. , 1998, The Journal of clinical investigation.

[13]  S. Sedimbi,et al.  SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients , 2007, Genes and Immunity.

[14]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[15]  The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis. , 2005, Rheumatology.

[16]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.

[17]  J. Haines,et al.  Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals. , 1999, Pharmacogenetics.

[18]  S. Rich,et al.  Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients , 2003, Journal of Human Genetics.

[19]  S. Werner.  Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. , 1977, The Journal of clinical endocrinology and metabolism.

[20]  M. Daly,et al.  Haplotype-based association analysis of 56 functional candidate genes in the IBD6 locus on chromosome 19 , 2006, European Journal of Human Genetics.

[21]  T. Tai,et al.  The Arg16Gly polymorphism of human β2‐adrenoreceptor is associated with type 2 diabetes in Taiwanese people , 2002, Clinical Endocrinology.

[22]  Sinead B. O'Leary,et al.  Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease , 2001, Nature Genetics.

[23]  Simon C. Potter,et al.  Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants , 2007, Nature Genetics.

[24]  R S Judson,et al.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R Staden,et al.  Automated detection of point mutations using fluorescent sequence trace subtraction. , 1998, Nucleic acids research.

[26]  M. Munakata,et al.  Molecular-based haplotype analysis of the beta 2-adrenergic receptor gene (ADRB2) in Japanese asthmatic and non-asthmatic subjects. , 2006, Allergology international : official journal of the Japanese Society of Allergology.

[27]  Yan Zhang,et al.  A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. , 2004, Nature genetics.

[28]  M. Pierer,et al.  Association between β2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope , 2008, Annals of the rheumatic diseases.

[29]  S. Shirasawa,et al.  Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. , 2001, Human molecular genetics.

[30]  Xiao-qing Liu,et al.  To the editor [3] , 2005 .

[31]  T. Ogihara,et al.  Association of SUMO4, as a Candidate Gene for IDDM5, with Susceptibility to Type 1 Diabetes in Asian Populations , 2006, Annals of the New York Academy of Sciences.

[32]  G. Barbesino,et al.  Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. , 2003, American journal of human genetics.

[33]  S. Pearce,et al.  No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves’ disease , 2005, Clinical endocrinology.

[34]  G. Chrousos,et al.  The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. , 2000, Pharmacological reviews.

[35]  J. She,et al.  In reply [5] , 2005 .

[36]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[37]  K. Bohren,et al.  A M55V Polymorphism in a Novel SUMO Gene (SUMO-4) Differentially Activates Heat Shock Transcription Factors and Is Associated with Susceptibility to Type I Diabetes Mellitus* , 2004, Journal of Biological Chemistry.

[38]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[39]  Yongsoo Park,et al.  Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes , 2005, Nature Genetics.